Ardelyx reported $203.52M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Amgen USD 51.86B 27M Jun/2026
Ardelyx USD 203.52M 683K Mar/2026
aTyr Pharma USD 1.72M 10.79M Mar/2026
Curis USD 29.43M 10.69M Jun/2024
Sanofi EUR 12.3B 3.42B Mar/2026
TG Therapeutics USD 745.39M 247K Jun/2026
United Therapeutics USD 100M 100M Jun/2024